Last reviewed · How we verify
AstroStem-V
At a glance
| Generic name | AstroStem-V |
|---|---|
| Sponsor | Nature Cell Co. Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Stem Cells for Erectile Dysfunction Post RALP (PHASE1, PHASE2)
- "An Intermediate Size Patient Population Expanded Access Protocol to Evaluate the Safety and Efficacy of Allogeneic HB-adMSCs (Hope Biosciences - Adipose Derived Mesenchymal Stem Cells) for the Treatment of Multiple System Atrophy."
- Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury (PHASE1, PHASE2)
- HB-adMSCs for the Treatment of Crohn's Disease (PHASE2)
- A Clinical Trial to Determine the Safety and Efficacy of Hope Biosciences Autologous Mesenchymal Stem Cell Therapy for the Treatment of Traumatic Brain Injury and Hypoxic-Ischemic Encephalopathy (PHASE1, PHASE2)
- HB-adMSCs vs Placebo for the Treatment of Juvenile Idiopathic Arthritis (PHASE2)
- Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD) (PHASE2)
- Intermediate Size Patient Population Expanded Access Protocol to Evaluate HB-adMSCs for the Treatment of Patients With Traumatic or Nontraumatic Brain Injury
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |